Evidence & regulatory context
- Mechanism
- Hepatocyte-like cells from human amniotic epithelial stem cells; cell therapy.
- Target
- Not recorded
- Injury models
- Chemical/toxin
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseChemical/toxinNOD-SCID (nonobese diabetic severe combined immunodeficient)Malen = n=8 per group for olive oil, carbon tetrachloride plus phos…Intravenous (tail vein)2 x 10^6 hepatocyte-like cells in 500 microlitres of phosph…4 hours after carbon tetrachloride administration
Model: Carbon tetrachloride-induced acute liver failure by intraperitoneal injection of 10 percent carbon tetrachloride in olive oil at 1 mL per kg body weight, with a lethal fulminant model at 3 mL per kg
Hepatocyte-like cell transplantation significantly reduced total bilirubin, transaminases and alkaline phosphatase and raised albumin, attenuated hepatocyte necrosis, engrafted in liver parenchyma and raised survival after lethal carbon tetrachloride from 0 of 8 to 6 of 8 mice.
Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.